Urinary biomarkers for bladder cancer diagnosis and NMIBC follow-up: a systematic review.
Fiche publication
Date publication
janvier 2023
Journal
World journal of urology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr ROY Catherine
Tous les auteurs :
Soorojebally Y, Neuzillet Y, Roumiguié M, Lamy PJ, Allory Y, Descotes F, Ferlicot S, Kassab-Chahmi D, Oudard S, Rébillard X, Roy C, Lebret T, Rouprêt M, Audenet F
Lien Pubmed
Résumé
Bladder cancer detection and follow-up is based on cystoscopy and/or cytology, but it remains imperfect and invasive. Current research focuses on diagnostic biomarkers that could improve bladder cancer detection and follow-up by discriminating patients at risk of aggressive cancer who need confirmatory TURBT (Transurethral Resection of Bladder Tumour) from patients at no risk of aggressive cancer who could be spared from useless explorations.
Mots clés
Biomarkers, Bladder cancer, Cystoscopy, Cytology, Diagnostic, Follow-up
Référence
World J Urol. 2023 01 2;: